Magdalene K. Cook
Chief Executive Officer presso Renovacor Holdings, Inc.
Profilo
Magdalene K.
Cook is currently the President, Chief Executive Officer & Director at Renovacor Holdings, Inc. and also works as a Research Associate at the University of Virginia.
Previously, she served as the Chairman, President & Chief Executive Officer at Renovacor, Inc. from 2018 to 2022.
She has also worked as a Director at CardioKine, Inc., LabNow, Inc., and as a Principal at iKnowMed, Inc. Additionally, she served as a Board Observer at ArgiNOx Pharmaceuticals, Inc. and as a Principal at Aisling Capital LLC.
Dr. Cook received her undergraduate degree from the University of Virginia and her doctorate from Columbia University College of Physicians & Surgeons.
Posizioni attive di Magdalene K. Cook
| Società | Posizione | Inizio |
|---|---|---|
| University of Virginia | Corporate Officer/Principal | - |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Chief Executive Officer | 01/08/2018 |
Precedenti posizioni note di Magdalene K. Cook
| Società | Posizione | Fine |
|---|---|---|
| RENOVACOR, INC. | Chief Executive Officer | 01/12/2022 |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Private Equity Investor | 31/12/2006 |
iKnowMed, Inc.
 iKnowMed, Inc. Internet Software/ServicesTechnology Services iKnowMed, Inc. operates a web-based oncology electronic medical records system that replaces paper charts to provide clinical patient information for physicians. The company was founded by Don Simborg and Robert J. Barcklay in 1996 and is headquartered in Berkeley, CA. | Corporate Officer/Principal | - |
ArgiNOx Pharmaceuticals, Inc.
 ArgiNOx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ArgiNOx Pharmaceuticals, Inc. focused on the discovery and development of medicines to treat hospitalized patients. The company's initial area of research and development is directed at nitric oxide-mediated pathways. Arginox's lead compound, Tilarginine Acetate Injection, is in late-stage clinical evaluation for the treatment of cardiogenic shock. The company was incorporated on March 24, 2004 and was headquartered in Redwood City, CA. | Corporate Officer/Principal | - |
CardioKine, Inc.
 CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Director/Board Member | - |
Formazione di Magdalene K. Cook
| University of Virginia | Undergraduate Degree |
| Columbia University College of Physicians & Surgeons | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
iKnowMed, Inc.
iKnowMed, Inc. Internet Software/ServicesTechnology Services iKnowMed, Inc. operates a web-based oncology electronic medical records system that replaces paper charts to provide clinical patient information for physicians. The company was founded by Don Simborg and Robert J. Barcklay in 1996 and is headquartered in Berkeley, CA. | Technology Services |
CardioKine, Inc.
CardioKine, Inc. Pharmaceuticals: MajorHealth Technology CardioKine, Inc. develops drugs and pharmaceuticals for the treatment and prevention of heart failure. The company was founded by Arthur Michael Feldman, James Mervis, Paul-Andre de Lame and Michael Juliano in 2004 and is headquartered in Pittsburgh, PA. | Health Technology |
ArgiNOx Pharmaceuticals, Inc.
ArgiNOx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ArgiNOx Pharmaceuticals, Inc. focused on the discovery and development of medicines to treat hospitalized patients. The company's initial area of research and development is directed at nitric oxide-mediated pathways. Arginox's lead compound, Tilarginine Acetate Injection, is in late-stage clinical evaluation for the treatment of cardiogenic shock. The company was incorporated on March 24, 2004 and was headquartered in Redwood City, CA. | Health Technology |
LabNow, Inc.
 LabNow, Inc. Medical SpecialtiesHealth Technology LabNow, Inc. manufactures medical, dental and hospital equipment and supplies pharmaceutical products. The company was founded on February 20, 2004 and is headquartered in Austin, TX. | Health Technology |
Aisling Capital LLC
Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Finance |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA. | Health Technology |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Renovacor, Inc. operates as a clinical stage gene therapy company. It researches and develops AAV-based gene therapies for BAG3 gene mutation-associated diseases. Its therapeutic focus is on cardiovascular diseases. The company was founded by Arthur Michael Feldman on June 7, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Magdalene K. Cook
